AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for CKD Stage 3

Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease NCT07493642NA1 site๐Ÿ“ New Taipei City Fu Jen Catholic University Hospital ยท Tests: Multimedia Health Education, Standard Education Group A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China NCT06933472Phase 342 sites๐Ÿ“ Granada Hills๐Ÿ“ San Dimas๐Ÿ“ San Dimas Alebund Pharmaceuticals ยท Tests: AP301, AP301 Low Dose Effects of Replacing High Protein Foods in People With Chronic Kidney Disease NCT07105670NA1 site๐Ÿ“ West Lafayette Indiana University ยท Tests: Controlled dietary intervention Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants NCT07494045Phase 25 sites๐Ÿ“ Kansas City๐Ÿ“ Columbus๐Ÿ“ Philadelphia OPKO Health, Inc. ยท Tests: CTAP101 A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis NCT06466785Phase 358 sites๐Ÿ“ Yerevan๐Ÿ“ Yerevan๐Ÿ“ Yerevan Genexine, Inc. ยท Tests: Efepoetin Alfa, Darbepoetin Alfa Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System NCT06360380NA10 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco๐Ÿ“ Minneapolis AquaPass Medical Ltd. ยท Tests: AquaPass System A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia NCT07494409Phase 31 site๐Ÿ“ Shanghai Kind Pharmaceuticals LLC ยท Tests: AND017 capsules, ESA Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS NCT05795140Phase 39 sites๐Ÿ“ Sรฃo Paulo๐Ÿ“ Rio de Janeiro๐Ÿ“ Beijing Novartis Pharmaceuticals ยท Tests: Iptcaopan 200 mg Prediction of Peripheral Neuropathy With Functional Testing NCT06933108n/a1 site๐Ÿ“ Le Mans Universitรฉ catholique de l'Ouest A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) NCT07624305Phase 3478 sites๐Ÿ“ Huntsville๐Ÿ“ Surprise๐Ÿ“ Tempe AstraZeneca ยท Tests: Balcinrenone/dapagliflozin, Dapagliflozin, Placebo matching Dapagliflozin, Placebo matching balcinrenone/dapagliflozin Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease NCT05732727Phase 340 sites๐Ÿ“ Angers๐Ÿ“ Bordeaux๐Ÿ“ Brest University Hospital, Tours ยท Tests: Antihypertensive algorithm, Standard of care Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients NCT05944016Phase 316 sites๐Ÿ“ Heidelberg๐Ÿ“ Mรผnchen๐Ÿ“ Mรผnchen University Hospital Goettingen ยท Tests: Dapagliflozin, Placebo A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) NCT03619850Phase 321 sites๐Ÿ“ Hollywood๐Ÿ“ Detroit๐Ÿ“ Kansas City AMAG Pharmaceuticals, Inc. ยท Tests: Ferumoxytol, Iron sucrose A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis NCT03633708Phase 343 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Kansas City Amgen ยท Tests: Etelcalcetide, Standard of Care A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis NCT07355062Phase 328 sites๐Ÿ“ Chula Vista๐Ÿ“ Los Angeles๐Ÿ“ Sacramento Renibus Therapeutics, Inc. ยท Tests: Veverimer, Placebo Patiromer and Diet/hrQoL in Chronic Dialysis NCT06858280Phase 31 site๐Ÿ“ Bergamo Mario Negri Institute for Pharmacological Research ยท Tests: Patiromer 8400 MG [Veltassa], Placebo Exercise Activity to Improve Mobility in Patients With CKD and PAD NCT06621264NA3 sites๐Ÿ“ Ferrara๐Ÿ“ Peschiera del Garda๐Ÿ“ Reggio Calabria University Hospital of Ferrara ยท Tests: EXERCISE TRAINING WITH OR WITHOUT MEDICATION, Control (Standard treatment) A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis NCT03969329Phase 323 sites๐Ÿ“ Ghent๐Ÿ“ Prague๐Ÿ“ Bron Amgen ยท Tests: Etelcalcetide Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes NCT06925217NA2 sites๐Ÿ“ Lausanne๐Ÿ“ Lausanne Heba Al-Alwan ยท Tests: CamAPS HX, Standard insulin therapy with CGM Phosphate Assessment in Chronic Kidney Disease Patients Study NCT07368946NA1 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Dietary Phosphorus Intake Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease NCT07483372Phase 11 site๐Ÿ“ Suzhou The First Affiliated Hospital with Nanjing Medical Universiโ€ฆ ยท Tests: SC101 Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation End Products in Patients With Stage III Chronic Kidney Disease NCT07729683NA1 site๐Ÿ“ La Rochelle Groupe Hospitalier de la Rochelle Rรฉ Aunis ยท Tests: Consumption of wakame A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) NCT07241390Phase 3566 sites๐Ÿ“ Bahรญa Blanca๐Ÿ“ Buenos Aires๐Ÿ“ Buenos Aires Eli Lilly and Company ยท Tests: Orforglipron, Placebo AK+ Guardโ„ข Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring NCT07210021n/a1 site๐Ÿ“ Eatontown AccurKardia, Inc. ยท Tests: AK+ Guardโ„ข ECG Application Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis NCT07759167Phase 11 site๐Ÿ“ Ghent Regeneron Pharmaceuticals ยท Tests: REGN9933, REGN7508, REGN9533, Heparin A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) NCT06721143Phase 1, Phase 22 sites๐Ÿ“ Miami๐Ÿ“ Miami AION Healthspan, Inc. ยท Tests: AION-301, Placebo Urinary Tubular Biomarkers for Chronic Kidney Disease NCT06732349n/a1 site๐Ÿ“ Rotterdam Erasmus Medical Center ยท Tests: Urinary tubular test panel Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) NCT06402851Phase 46 sites๐Ÿ“ Salvador๐Ÿ“ Brasรญlia๐Ÿ“ Campo Grande Hospital Sirio-Libanes ยท Tests: Anticoagulant Oral Prospective Analysis of Self Medication With Phytotherapy in Nephropatic Patients. NCT07444515NA4 sites๐Ÿ“ Saint-Benoรฎt๐Ÿ“ Saint-Denis๐Ÿ“ Saint-Paul Centre Hospitalier Universitaire de la Rรฉunion ยท Tests: series of questions which can change patient care ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases NCT07187713Phase 41 site๐Ÿ“ Giza Ace Cells Lab Limited ยท Tests: ACE Reno
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy